liver cancer
Conditions
Interventions
Precision treatment group:Treatment based on drug sensitivity test and gene test results
Empirical treatment group:Empirical treatment
Sponsors
First Affiliated Hospital of Chongqing Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Patients with clinical diagnosis of primary liver cancer; 2. Patients with the pathological results proved to be the reexamination of liver cancer. 3. Patients with recurrent liver cancer after operation.
Exclusion criteria
Exclusion criteria: 1. Because the patient individual factor is not willing to cooperate with the treatment; 2. Other factors: liver cancer tissue is too small to obtain, specimen contamination can not be cultured, perioperative period due to other factors such as accidental death.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumor recurrence rate;One-year survival rate;5-year survival rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Reoperation rate;Incidence of adverse reactions to chemotherapy; | — |
Countries
China
Contacts
Public ContactShi Zhengrong
Outcome results
None listed